Organigram Ships First Medical Cannabis to Germany, Expands EU Reach
Ticker: OGI · Form: 6-K · Filed: Jan 31, 2024 · CIK: 1620737
| Field | Detail |
|---|---|
| Company | Organigram Holdings INC. (OGI) |
| Form Type | 6-K |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: international-expansion, medical-cannabis, market-entry
TL;DR
**Organigram just shipped weed to Germany, big international growth move!**
AI Summary
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced on January 31, 2024, that it completed its first shipment of medical cannabis to Germany, marking a significant expansion of its international operations. This move is crucial for investors as it demonstrates Organigram's ability to tap into new, potentially lucrative European markets, which could drive future revenue growth beyond its domestic Canadian market.
Why It Matters
This filing signals Organigram's successful entry into the German medical cannabis market, a key step in its international growth strategy that could lead to increased sales and market share.
Risk Assessment
Risk Level: low — This filing reports a positive business development, indicating expansion rather than a new risk.
Analyst Insight
Investors should monitor Organigram's upcoming earnings reports for specific revenue contributions from the German market, as successful expansion could signal strong future growth potential.
Key Players & Entities
- Organigram Holdings Inc. (company) — the registrant expanding its international reach
- Germany (country) — the destination for Organigram's first international medical cannabis shipment
- January 31, 2024 (date) — the date of the press release and the 6-K filing
- Greg Guyatt (person) — Chief Financial Officer who signed the 6-K report
Forward-Looking Statements
- Organigram's international revenue will increase in the next fiscal year due to expansion into the German market. (Organigram Holdings Inc.) — medium confidence, target: September 30, 2025
FAQ
What is the primary news reported in Organigram Holdings Inc.'s 6-K filing dated January 31, 2024?
The primary news reported is that Organigram Holdings Inc. completed its first shipment of medical cannabis to Germany, extending its international reach.
Which stock exchanges is Organigram Holdings Inc. listed on, according to the filing?
According to the filing, Organigram Holdings Inc. is listed on NASDAQ (OGI) and TSX (OGI).
Who signed the 6-K report on behalf of Organigram Holdings Inc. and what is their title?
The 6-K report was signed by Greg Guyatt, who holds the title of Chief Financial Officer for Organigram Holdings Inc.
What is the Commission File Number for Organigram Holdings Inc. as stated in the 6-K filing?
The Commission File Number for Organigram Holdings Inc. is 001-38885, as stated in the 6-K filing.
Does Organigram Holdings Inc. file annual reports under Form 20-F or Form 40-F?
Organigram Holdings Inc. indicates by check mark that it files annual reports under Form 40-F.
Filing Stats: 199 words · 1 min read · ~1 pages · Grade level 12.4 · Accepted 2024-01-31 08:36:42
Filing Documents
- a53889975.htm (6-K) — 6KB
- a53889975ex99_1.htm (EX-99.1) — 7KB
- 0001157523-24-000138.txt ( ) — 14KB
From the Filing
HOLDINGS INC. 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ ] Form 40-F [ X ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] SUBMITTED HEREWITH Exhibits 99.1 Press Release dated January 31, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ORGANIGRAM HOLDINGS INC. /s/ Greg Guyatt Greg Guyatt Chief Financial Officer Date: January 31, 2024